With this approval, FluMist becomes the first vaccine to prevent influenza that does not need to be administered by a health care provider. Influenza Vaccine Live (FluMist; AstraZeneca) is now FDA ...
The approval is indicated for adults and children aged 2 years and older, making arimoclomol (Miplyffa) the first drug approved by the FDA to treat NPC. The FDA has approved the first drug to treat ...
In a recently-published study, results demonstrated that residence in low-income, low-food access neighborhoods in early life was linked to higher subsequent child body mass index (BMI) and higher ...
Previous research has associated poor health outcomes and increased health care use with household food insecurity (HFI), which can be dependent on context and environmental stressors, such as ...
The FDA has granted Breakthrough Therapy Designation for oral infigratinib (BridgeBio Pharma), which is currently under development for children with achondroplasia, according to a press release from ...
Pediatric patients treated with Janus kinase inhibitors (JAKi) reporting adverse events (AEs) report higher numbers of lymphatic and blood disorders, recent findings suggest, whereas adults aged 18 ...
Probiotics: Beneficial to pediatric population during antibiotic treatment?
FDA approves neffy as first nasal spray to treat anaphylaxis ...
Probiotics: Beneficial to pediatric population during antibiotic treatment?
Probiotics: Beneficial to pediatric population during antibiotic treatment?
Probiotics: Beneficial to pediatric population during antibiotic treatment?
Probiotics: Beneficial to pediatric population during antibiotic treatment?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback